ITOS
Price
$11.76
Change
+$0.04 (+0.34%)
Updated
Apr 15, 6:59 PM EST
24 days until earnings call
NTLA
Price
$22.92
Change
-$1.35 (-5.56%)
Updated
Apr 15, 6:59 PM EST
17 days until earnings call
Ad is loading...

Compare trend and price ITOS vs NTLA

Header iconITOS vs NTLA Comparison
Open Charts ITOS vs NTLABanner chart's image
iTeos Therapeutics
Price$11.76
Change+$0.04 (+0.34%)
Volume$61.14K
CapitalizationN/A
Intellia Therapeutics
Price$22.92
Change-$1.35 (-5.56%)
Volume$845.7K
CapitalizationN/A
View a ticker or compare two or three
ITOS vs NTLA Comparison Chart

Loading...

ITOSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
NTLADaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ITOS vs. NTLA commentary
Apr 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITOS is a Hold and NTLA is a Hold.

COMPARISON
Comparison
Apr 16, 2024
Stock price -- (ITOS: $13.35 vs. NTLA: $27.22)
Brand notoriety: ITOS and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ITOS: 96% vs. NTLA: 54%
Market capitalization -- ITOS: $488.9M vs. NTLA: $2.62B
ITOS [@Biotechnology] is valued at $488.9M. NTLA’s [@Biotechnology] market capitalization is $2.62B. The market cap for tickers in the [@Biotechnology] industry ranges from $568.84B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ITOS’s FA Score shows that 1 FA rating(s) are green whileNTLA’s FA Score has 0 green FA rating(s).

  • ITOS’s FA Score: 1 green, 4 red.
  • NTLA’s FA Score: 0 green, 5 red.
According to our system of comparison, ITOS is a better buy in the long-term than NTLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ITOS’s TA Score shows that 6 TA indicator(s) are bullish while NTLA’s TA Score has 3 bullish TA indicator(s).

  • ITOS’s TA Score: 6 bullish, 4 bearish.
  • NTLA’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ITOS is a better buy in the short-term than NTLA.

Price Growth

ITOS (@Biotechnology) experienced а +17.62% price change this week, while NTLA (@Biotechnology) price change was +1.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.71%. For the same industry, the average monthly price growth was +6.49%, and the average quarterly price growth was +103.81%.

Reported Earning Dates

ITOS is expected to report earnings on May 09, 2024.

NTLA is expected to report earnings on May 02, 2024.

Industries' Descriptions

@Biotechnology (+4.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ITOS with price predictions.
OPEN
A.I.dvisor published
a Summary for NTLA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
NTLA($2.62B) has a higher market cap than ITOS($489M). ITOS YTD gains are higher at: 21.918 vs. NTLA (-10.725). ITOS has higher annual earnings (EBITDA): -143.99M vs. NTLA (-506.32M). NTLA has more cash in the bank: 912M vs. ITOS (532M). ITOS has less debt than NTLA: ITOS (6.06M) vs NTLA (115M). NTLA has higher revenues than ITOS: NTLA (36.3M) vs ITOS (12.6M).
ITOSNTLAITOS / NTLA
Capitalization489M2.62B19%
EBITDA-143.99M-506.32M28%
Gain YTD21.918-10.725-204%
P/E Ratio41.49N/A-
Revenue12.6M36.3M35%
Total Cash532M912M58%
Total Debt6.06M115M5%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
88
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
75
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ITOSNTLA
RSI
ODDS (%)
Bearish Trend 15 days ago
89%
Bearish Trend 15 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 15 days ago
89%
Bullish Trend 15 days ago
74%
Momentum
ODDS (%)
Bullish Trend 15 days ago
81%
Bearish Trend 15 days ago
87%
MACD
ODDS (%)
Bullish Trend 15 days ago
77%
Bearish Trend 15 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 15 days ago
79%
Bullish Trend 15 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 15 days ago
77%
Bearish Trend 15 days ago
86%
Advances
ODDS (%)
Bullish Trend 19 days ago
75%
Bullish Trend 19 days ago
77%
Declines
ODDS (%)
Bearish Trend about 1 month ago
79%
Bearish Trend 21 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 15 days ago
86%
Bearish Trend 19 days ago
90%
Aroon
ODDS (%)
Bullish Trend 15 days ago
78%
Bullish Trend 15 days ago
77%
View a ticker or compare two or three
Ad is loading...
ITOSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
NTLADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PPSFX20.86N/A
N/A
Principal Large Cap Value III R3
HRVIX37.59N/A
N/A
Heartland Value Plus Investor
ICNGX16.15N/A
N/A
Delaware International Equity II R6
RWIGX64.68-0.13
-0.20%
American Funds Capital World Gr&Inc R6
FIVLX10.46-0.09
-0.85%
Fidelity International Value